Novel cubosome based system for ocular delivery of acetazolamide

References

• Allison K, Patel D, Alabi OJC. (2020). Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus 12:1–9.
   Web of Science ®Google Scholar
• Ammar HO, Salama H, Ghorab M, Mahmoud A. (2009). Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech 10:808–19.
   PubMed Web of Science ®Google Scholar
• Baeyens V, Felt-Baeyens O, Rougier S, et al. (2002). Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs. J Controlled Release 85:163–8.
   PubMed Web of Science ®Google Scholar
• Barar J, Javadzadeh AR, Omidi Y. (2008). Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv 5:567–81.
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Vicario-De-La-Torre M, Andrés-Guerrero V, et al. (2016). Novel water-soluble mucoadhesive carbosilane dendrimers for ocular administration. Mol Pharm 13:2966–76.
   PubMedGoogle Scholar
• Cantor LB. (2006). Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag 2:337–46.
   PubMedGoogle Scholar
• Chen Y, Ma P, Gui S. (2014). Cubic and hexagonal liquid crystals as drug delivery systems. Biomed Res Int 2014:815981–12.
   PubMed Web of Science ®Google Scholar
• Eldeeb AE, Salah S, Ghorab M. (2019). Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Delivery Sci Technol 52:236–47.
   Web of Science ®Google Scholar
• Elgindy N, Mehanna M, Mohyeldin S. (2016). Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm 501:167–79.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, et al. (2005). Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 22:2163–73.
   PubMed Web of Science ®Google Scholar
• Gaballa SA, El Garhy OH, Moharram H, Abdelkader H. (2020). Preparation and evaluation of cubosomes/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res 37:1–23.
   Web of Science ®Google Scholar
• Gan L, Han S, Shen J, et al. (2010). Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 396:179–87.
   PubMed Web of Science ®Google Scholar
• Gan L, Wang J, Jiang M, et al. (2013). Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 18:290–7.
   PubMed Web of Science ®Google Scholar
• Granero GE, Longhi MR, Becker C, et al. (2008). Biowaiver monographs for immediate release solid oral dosage forms: acetazolamide. J Pharm Sci 97:3691–9.
   PubMed Web of Science ®Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82.
   PubMed Web of Science ®Google Scholar
• Gupta H, Jain S, Mathur R, et al. (2007). Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Delivery 14:507–15.
   PubMed Web of Science ®Google Scholar
• Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. (1996). Cubic lipid–water phase dispersed into submicron particles. Langmuir 12:4611–3.
   Web of Science ®Google Scholar
• Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. (1997). Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13:6964–71.
   Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1–12.
   PubMed Web of Science ®Google Scholar
• Hegde RR, Bhattacharya SS, Verma A, Ghosh A. (2014). Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma. Curr Eye Res 39:155–63.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. (2002). Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268–79.
   PubMed Web of Science ®Google Scholar
• Huang J, Peng T, Li Y, et al. (2017). Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. AAPS PharmSciTech 18:2919–26.
   PubMed Web of Science ®Google Scholar
• Hundekar YR, Saboji J, Patil S, Nanjwade B. (2014). Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. World J Pharma Pharma Sci 3:523–39.
   Google Scholar
• Kaur IP, Smitha R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28:353–69.
   PubMed Web of Science ®Google Scholar
• Kohli A, Alpar H. (2004). Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 275:13–7.
   PubMed Web of Science ®Google Scholar
• Larsson K. (1989). Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem 93:7304–14.
   Web of Science ®Google Scholar
• Loftsson T, Frithriksdottir H, Stefansson E, et al. (1994). Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J Pharm Pharmacol 46:503–4.
   PubMed Web of Science ®Google Scholar
• Mahmoud SS, Elabrak ES, Aly MA, Ali EM. (2019). Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve. PLoS One 14:e0212588.
   PubMed Web of Science ®Google Scholar
• Matloub AA, Abousamra MM, Salama AH, et al. (2018). Cubic liquid crystalline nanoparticles containing a polysaccharide from Ulva fasciata with potent antihyperlipidaemic activity. Saudi Pharm J 26:224–31.
   PubMed Web of Science ®Google Scholar
• Mishra V, Jain N. (2014). Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits. Int J Pharm 461:380–90.
   PubMed Web of Science ®Google Scholar
• Mohyeldin SM, Mehanna MM, Elgindy NA. (2016). Superiority of liquid crystalline cubic nanocarriers as hormonal transdermal vehicle: comparative human skin permeation-supported evidence. Expert Opin Drug Deliv 13:1049–64.
   PubMed Web of Science ®Google Scholar
• Morsi N, Ibrahim M, Refai H, El Sorogy H. (2017). Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide. Eur J Pharm Sci 104:302–14.
   PubMed Web of Science ®Google Scholar
• Morsi NM, Mohamed MI, Refai H, El Sorogy HM. (2014). Nanoemulsion as a novel ophthalmic delivery system for acetazolamide. Int J Pharm Pharm Sci 6:227–36.
   Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, et al. (2008). Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharma Biopharm 68:513–25.
   PubMed Web of Science ®Google Scholar
• Muchtar S, Abdulrazik M, Frucht-Pery J, Benita S. (1997). Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea. J Controlled Release 44:55–64.
   Web of Science ®Google Scholar
• Mudgil M, Pawar PK. (2013). Preparation and in vitro/ex vivo evaluation of moxifloxacin-loaded PLGA nanosuspensions for ophthalmic application. Sci Pharm 81:591–606.
   PubMedGoogle Scholar
• Naguib SS, Hathout RM, Mansour S. (2017). Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug. Drug Deliv 24:99–108.
   PubMed Web of Science ®Google Scholar
• Occhiutto ML, Maranhão RC, Costa VP, Konstas AG. (2020). Nanotechnology for medical and surgical glaucoma therapy–a review. Adv Ther 37:155–99.
   PubMed Web of Science ®Google Scholar
• Rathod LV, Kapadia R, Sawant KK. (2017). A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: in vitro, in vivo and stability studies. Mater Sci Eng C 71:529–40.
   PubMed Web of Science ®Google Scholar
• Rizwan S, Hanley T, Boyd BJ, et al. (2009). Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci 98:4191–204.
   PubMed Web of Science ®Google Scholar
• Scriven LE. (1976). Equilibrium bicontinuous structure. Nature 263:123–5.
   Web of Science ®Google Scholar
• Shanmugam S, Ramvignesh T, Sundaramoorthy K, et al. (2011). Design and evaluation of novel ophthalmic delivery system of acyclovir for herpes simplex infection. Res J Pharma Biol Chem Sci 2:802–14.
   Google Scholar
• Singh J, Chhabra G, Pathak K. (2014). Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro, ex vivo evaluation and pharmacodynamic study. Drug Dev Ind Pharm 40:1223–32.
   PubMed Web of Science ®Google Scholar
• Svensson O, Thuresson K, Arnebrant T. (2008). Interactions between drug delivery particles and mucin in solution and at interfaces. Langmuir 24:2573–9.
   PubMed Web of Science ®Google Scholar
• Verma P, Ahuja M. (2016). Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide. Drug Deliv 23:3043–54.
   PubMed Web of Science ®Google Scholar
• Yadav M, Ahuja M. (2010). Preparation and evaluation of nanoparticles of gum cordia, an anionic polysaccharide for ophthalmic delivery. Carbohydr Polym 81:871–7.
   Web of Science ®Google Scholar
• Yang SC, Benita S. (2000). Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev Res 50:476–86.
   Web of Science ®Google Scholar
• Younes NF, Abdel-Halim SA, Elassasy AI. (2018). Corneal targeted sertaconazole nitrate loaded cubosomes: Preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm 553:386–97.
   PubMed Web of Science ®Google Scholar